Parkinson’s found to alter eye’s retina, impact vision in new study
Significant alterations in the structure and function of the eye’s retina — the layer at the very back of the…
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Significant alterations in the structure and function of the eye’s retina — the layer at the very back of the…
People with Parkinson’s disease whose electrical brain wave activity declines more slowly during deep sleep develop levodopa-induced dyskinesia (LID),…
Future Leaders in Canadian Brain Research, a Brain Canada program, has awarded two early-career scientists CA$100,000 (about $74,180) each…
A high dose of the investigational oral therapy mesdopetam led to a significant and clinically meaningful reduction in levodopa-induced…
Osteoporosis, a condition marked by fragile bones and very low bone mineral density (BMD), was associated with an increased risk…
Adhering to healthy plant-based dietary patterns was associated with a reduced risk of developing Parkinson’s disease, especially among older…
Exposure to alpha-synuclein, a protein that accumulates in the brains of Parkinson’s disease patients, led to inflammation and damage…
Racial disparities exist in the use of deep brain stimulation among people with Parkinson’s disease, a real-world claims…
Problems in quality control processes that support the health and function of mitochondria, crucial for cellular energy, are evident in…
NodThera’s NT-0796, an investigational oral therapy for Parkinson’s disease, reduced several inflammatory markers in elderly volunteers in seven days,…
Get regular updates to your inbox.